Dendritic cell-based immunotherapy

被引：676

作者：

Sabado, Rachel L. ^{[1
]}

Balan, Sreekumar ^{[1
]}

Bhardwaj, Nina ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

来源：

CELL RESEARCH | 2017年 / 27卷 / 01期

关键词：

dendritic cell; immunotherapy; CERVICAL-CANCER PATIENTS; REGULATORY T-CELLS; INTEGRATED IMMUNE-RESPONSE; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IN-VIVO; SIPULEUCEL-T; LYMPH-NODES; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY;

D O I：

10.1038/cr.2016.157

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.

引用

页码：74 / 95

页数：22

共 239 条

[1] Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells [J].

Aarntzen, Erik H. J. G. ;

Srinivas, Mangala ;

Bonetto, Fernando ;

Cruz, Luis J. ;

Verdijk, Pauline ;

Schreibelt, Gerty ;

van de Rakt, Mandy ;

Lesterhuis, W. Joost ;

van Riel, Maichel ;

Punt, Cornelius J. A. ;

Adema, Gosse J. ;

Heerschap, Arend ;

Figdor, Carl G. ;

Oyen, Wim J. ;

de Vries, I. Jolanda M. .

CLINICAL CANCER RESEARCH, 2013, 19 (06) :1525-1533

[2] How vitamin A metabolizing dendritic cells are generated in the gut mucosa [J].

Agace, William W. ;

Persson, Emma K. .

TRENDS IN IMMUNOLOGY, 2012, 33 (01) :42-48

[3] Toll-like receptor signalling [J].

Akira, S ;

Takeda, K .

NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511

[4] Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results [J].

Amin, Asim ;

Dudek, Arkadiusz Z. ;

Logan, Theodore F. ;

Lance, Raymond S. ;

Holzbeierlein, Jeffrey M. ;

Knox, Jennifer J. ;

Master, Viraj A. ;

Pal, Sumanta K. ;

Miller, Wilson H., Jr. ;

Karsh, Lawrence I. ;

Tcherepanova, Irina Y. ;

DeBenedette, Mark A. ;

Williams, W. Lee ;

Plessinger, Douglas C. ;

Nicolette, Charles A. ;

Figlin, Robert A. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3

[5] Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers [J].

Anandasabapathy, N. ;

Breton, G. ;

Hurley, A. ;

Caskey, M. ;

Trumpfheller, C. ;

Sarma, P. ;

Pring, J. ;

Pack, M. ;

Buckley, N. ;

Matei, I. ;

Lyden, D. ;

Green, J. ;

Hawthorne, T. ;

Marsh, H. C. ;

Yellin, M. ;

Davis, T. ;

Keler, T. ;

Schlesinger, S. J. .

BONE MARROW TRANSPLANTATION, 2015, 50 (07) :924-930

[6]

Aptsiauri N, 2007, ADV EXP MED BIOL, V601, P123

[7] Immune Activation and a 9-Year Ongoing Complete Remission Following CD40 Antibody Therapy and Metastasectomy in a Patient with Metastatic Melanoma [J].

Bajor, David L. ;

Xu, Xiaowei ;

Torigian, Drew A. ;

Mick, Rosemarie ;

Garcia, Laura R. ;

Richman, Lee P. ;

Desmarais, Cindy ;

Nathanson, Katherine L. ;

Schuchter, Lynn M. ;

Kalos, Michael ;

Vonderheide, Robert H. .

CANCER IMMUNOLOGY RESEARCH, 2014, 2 (11) :1051-1058

[8] Immunobiology of dendritic cells [J].

Banchereau, J ;

Briere, F ;

Caux, C ;

Davoust, J ;

Lebecque, S ;

Liu, YT ;

Pulendran, B ;

Palucka, K .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+

[9] Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA [J].

Barrou, B ;

Benoît, GR ;

Ouldkaci, M ;

Cussenot, O ;

Salcedo, M ;

Agrawal, S ;

Massicard, SV ;

Bercovici, N ;

Ericson, ML ;

Thiounn, N .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (05) :453-460

[10] Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer [J].

Battaglia, Alessandra ;

Buzzonetti, Alexia ;

Baranello, Cinzia ;

Ferrandina, Gabriella ;

Martinelli, Enrica ;

Fanfani, Francesco ;

Scambia, Giovanni ;

Fattorossi, Andrea .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (09) :1363-1373

← 1 2 3 4 5 6 7 8 9 10 →